What does ScarPro do?

ScarPro is a wholesaler in Aalter. Public Limited, started on 30 September 1993, 1 establishment.

What is the address of ScarPro?

The registered office of ScarPro is located at Lobulckstraat 3, 9880 Aalter.

Is ScarPro still active?

Yes. According to the CBE (30 October 2026) ScarPro is active, legal situation “Normale toestand”, started on 30 September 1993.

Is ScarPro registered on Peppol?

Yes, ScarPro is registered on the Peppol network with ID 0208:0451049505.

What is the enterprise number of ScarPro?

The enterprise number of ScarPro is BE0451049505.

When was ScarPro founded?

ScarPro was founded on 30 September 1993.

Who are the directors of ScarPro?

According to the 2025 annual accounts, the directors of ScarPro are: BAP MEDICAL B.V..

Is ScarPro a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 September 1993; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ScarPro make in 2025?

ScarPro posted a profit after taxes of € 3,105,582 in financial year 2025.

What is the revenue of ScarPro?

As a small company, ScarPro is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 4,663,732.

How much does an employee at ScarPro earn?

The average wage cost per full-time employee at ScarPro was € 56,100 in 2025: staff costs of € 1.7 million for 30.4 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does ScarPro have?

According to the 2025 annual accounts, ScarPro has 30.4 full-time equivalents (FTE).

ScarPro (Public Limited) - Aalter - BE0451049505

Dossier ScarPro, printed on 30 October 2026 from databakkes.be/en/0451049505/scarpro. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

ScarPro from Aalter, company number BE0451049505, closed financial year 2025 with a result of € 3.1 million after tax. For that financial year ScarPro recorded a gross margin of € 4.7 million and equity of € 1.8 million. Compared with financial year 2024, the result moved from € -2.6 million to € 3.1 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 19, 2026.

What it is worth Growing

€ 1.8 million

▲ € 3.1 million vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 3.1 million

▲ still € 2.6 million loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 304,475

▲ € 302,448 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.7 million.

People and assets in 2025

Full-time equivalents

30.4

▲ 7.8 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 1.7 million

▲ 29% vs 2024

€ 56,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 398,238

▼ 1% vs 2024

Of which on lease € 297,231.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 1.2 million

▼ 5% vs 2024

€ 489,570 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 548,593

▼ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 305,176

▲ 143% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 1,835,110 Gross margin 2022: € 1,835,110 First fiscal year in the series	€ 1,189,620 Gross margin 2023: € 1,189,620 ▼ 35% vs 2022 (€ 1,835,110) Unfavourable step	€ 2,016,442 Gross margin 2024: € 2,016,442 ▲ 70% vs 2023 (€ 1,189,620) Favourable step	€ 4,663,732 Gross margin 2025: € 4,663,732 ▲ 131% vs 2024 (€ 2,016,442) Favourable step	▲ 131%
Profit after taxes	€ 672,094 Profit after taxes 2022: € 672,094 First fiscal year in the series	€ -138,569 Profit after taxes 2023: € -138,569 ▼ € 810,662 vs 2022 (€ 672,094) Unfavourable step	€ -2,604,873 Profit after taxes 2024: € -2,604,873 ▼ € 2.5 million vs 2023 (€ -138,569) Unfavourable step	€ 3,105,582 Profit after taxes 2025: € 3,105,582 ▲ € 5.7 million vs 2024 (€ -2,604,873) Favourable step	▲ € 5.7 million
Equity	€ 1,389,016 Equity 2022: € 1,389,016 First fiscal year in the series	€ 1,250,447 Equity 2023: € 1,250,447 ▼ 10% vs 2022 (€ 1,389,016) Unfavourable step	€ -1,354,426 Equity 2024: € -1,354,426 ▼ € 2.6 million vs 2023 (€ 1,250,447) Unfavourable step	€ 1,751,156 Equity 2025: € 1,751,156 ▲ € 3.1 million vs 2024 (€ -1,354,426) Favourable step	▲ € 3.1 million
Total debts	€ 3,728,818 Total debts 2022: € 3,728,818 First fiscal year in the series	€ 4,501,377 Total debts 2023: € 4,501,377 ▲ 21% vs 2022 (€ 3,728,818) Unfavourable step	€ 5,717,552 Total debts 2024: € 5,717,552 ▲ 27% vs 2023 (€ 4,501,377) Unfavourable step	€ 5,224,957 Total debts 2025: € 5,224,957 ▼ 9% vs 2024 (€ 5,717,552) Favourable step	▼ 9%
Cash	€ 78,784 Cash 2022: € 78,784 First fiscal year in the series	€ 441 Cash 2023: € 441 ▼ 99% vs 2022 (€ 78,784) Unfavourable step	€ 2,026 Cash 2024: € 2,026 ▲ € 1,585 vs 2023 (€ 441) Favourable step	€ 304,475 Cash 2025: € 304,475 ▲ € 302,448 vs 2024 (€ 2,026) Favourable step	▲ € 302,448
Retained profit	€ 1,327,516 Retained profit 2022: € 1,327,516 First fiscal year in the series	€ 1,188,947 Retained profit 2023: € 1,188,947 ▼ 10% vs 2022 (€ 1,327,516) Unfavourable step	€ -1,415,926 Retained profit 2024: € -1,415,926 ▼ € 2.6 million vs 2023 (€ 1,188,947) Unfavourable step	€ 1,689,656 Retained profit 2025: € 1,689,656 ▲ € 3.1 million vs 2024 (€ -1,415,926) Favourable step	▲ € 3.1 million
Bank debt	€ 1,384,261 Bank debt 2022: € 1,384,261 First fiscal year in the series	€ 1,298,042 Bank debt 2023: € 1,298,042 ▼ 6% vs 2022 (€ 1,384,261) Favourable step	€ 1,222,231 Bank debt 2024: € 1,222,231 ▼ 6% vs 2023 (€ 1,298,042) Favourable step	€ 1,155,923 Bank debt 2025: € 1,155,923 ▼ 5% vs 2024 (€ 1,222,231) Favourable step	▼ 5%
Balance sheet total	€ 5,117,833 Balance sheet total 2022: € 5,117,833 First fiscal year in the series	€ 5,751,825 Balance sheet total 2023: € 5,751,825 ▲ 12% vs 2022 (€ 5,117,833) Unchanged	€ 4,626,036 Balance sheet total 2024: € 4,626,036 ▼ 20% vs 2023 (€ 5,751,825) Unchanged	€ 6,976,114 Balance sheet total 2025: € 6,976,114 ▲ 51% vs 2024 (€ 4,626,036) Unchanged	▲ 51%
Employees (FTE)	15.8 Employees (FTE) 2022: 15.8 First fiscal year in the series	22.6 Employees (FTE) 2023: 22.6 ▲ 6.8 vs 2022 (15.8) Unchanged	22.6 Employees (FTE) 2024: 22.6 Unchanged (22.6) Unchanged	30.4 Employees (FTE) 2025: 30.4 ▲ 7.8 vs 2024 (22.6) Unchanged	▲ 7.8

Key figures of ScarPro, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ScarPro?

What happened at ScarPro in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 19, 2026 New annual accounts for financial year 2025: profit of € 3.1 million. filed late Source: NBB ↗
2025 BAP MEDICAL B.V. became a director. NBB
Mar 11, 2019 New establishment in Aalter. KBO
Sep 30, 1993 Start of the company according to the CBE. KBO

In short

From € 672,094 profit in 2022 to € 3.1 million profit in 2025.

Paid € 560,967 in corporate taxes since 2022.

Best year ever: 2025, with € 3.1 million profit.

On average € 153,400 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BAP MEDICAL HOLDING BELGIUM 100%

The stake of BAP MEDICAL HOLDING BELGIUM comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

ScarPro

Behind ScarPro is BAP MEDICAL B.V.. The shares are held by BAP MEDICAL HOLDING BELGIUM (100%).

Directors

According to the 2025 annual accounts

BAP MEDICAL B.V.

Director · represented by Rob Hollweg

Also active at: BAP MEDICAL HOLDING BELGIUM

since 2025

Shareholders

BAP MEDICAL HOLDING BELGIUM

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lobulckstraat 3

9880 Aalter

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

BAP MEDICAL HOLDING BELGIUM same network

€ -1,062 gross margin · 2025

SBT Lab

€ -450,130 gross margin · 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0451.049.505
VAT number: BE 0451.049.505
Registered office: Lobulckstraat 3, 9880 Aalter
Names & denominations: ScarPro
Enterprise type: Rechtspersoon
Legal form: Public limited company
Legal situation: Normale toestand
Start date: 30 September 1993
Peppol: Active · Active since 11 Nov 2025
Activities · NACE: Groothandel in farmaceutische en medische artikelen

View on CBE Public ↗ Annual accounts (NBB) ↗